Peter Joyce
Company: Grey Wolf Therapeutics
Job title: Chief Executive Officer, Co-Founder
Seminars:
Targeting ERAP1 to Alter the Cancer Immunopeptidome 10:30 am
day: Day One
October 26 - 28, 2021 | Digital Event
9.00am - 6.00pm ET | 6.00am - 3.00pm PT
180+ Attendees | 90+ Organizations | 40+ World Class Speakers